Next Article in Journal
Targeting Protein Synthesis in Colorectal Cancer
Next Article in Special Issue
Cancer Stem Cell-Inducing Media Activates Senescence Reprogramming in Fibroblasts
Previous Article in Journal
Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner
Previous Article in Special Issue
Senescence and Cancer: Role of Nitric Oxide (NO) in SASP
Article

HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth

1
Institute of Biochemistry, Emil-Fischer Zentrum, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany
2
Comprehensive Cancer Center (CCC) Erlangen-EMN, 91054 Erlangen, Germany
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(5), 1299; https://doi.org/10.3390/cancers12051299
Received: 12 March 2020 / Revised: 15 May 2020 / Accepted: 16 May 2020 / Published: 21 May 2020
(This article belongs to the Special Issue Senescence and Cancer)
In addition to genetic changes, post-transcriptional events strongly contribute to the progression of malignant tumors. The RNA-binding protein HuR (ELAVL1) is able to bind and stabilize a large group of target mRNAs, which contain AU-rich elements (ARE) in their 3′-untranslated region. We found HuR to be upregulated in malignant melanoma in vitro and in vivo, significantly correlating with progression in vivo. Additionally, we could show that miR-194-5p can regulate HuR expression level. HuR knockdown in melanoma cells led to the suppression of proliferation and the induction of cellular senescence. Interestingly, HuR overexpression was sufficient to inhibit senescence in BRAFV600E-expressing melanocytes and to force their growth. Here, MITF (Microphthalmia-associated transcription factor), a key player in suppressing senescence and an ARE containing transcript, is positively regulated by HuR. Our results show for the first time that the overexpression of HuR is an important part of the regulatory pathway in the development of malignant melanoma and functions as a switch to overcome oncogene-induced senescence and to support melanoma formation. These newly defined alterations may provide possibilities for innovative therapeutic approaches. View Full-Text
Keywords: malignant melanoma; HuR; oncogene induced senescence; MITF; Microphthalmia-associated transcription factor malignant melanoma; HuR; oncogene induced senescence; MITF; Microphthalmia-associated transcription factor
Show Figures

Graphical abstract

MDPI and ACS Style

Liebig, J.K.; Kuphal, S.; Bosserhoff, A.K. HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth. Cancers 2020, 12, 1299. https://doi.org/10.3390/cancers12051299

AMA Style

Liebig JK, Kuphal S, Bosserhoff AK. HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth. Cancers. 2020; 12(5):1299. https://doi.org/10.3390/cancers12051299

Chicago/Turabian Style

Liebig, Janika K., Silke Kuphal, and Anja K. Bosserhoff 2020. "HuRdling Senescence: HuR Breaks BRAF-Induced Senescence in Melanocytes and Supports Melanoma Growth" Cancers 12, no. 5: 1299. https://doi.org/10.3390/cancers12051299

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop